Barclays’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3K | Sell |
2,800
-16,378
| -85% | -$17.5K | ﹤0.01% | 4245 |
|
|
2025
Q1 | $22K | Sell |
19,178
-7,125
| -27% | -$8.17K | ﹤0.01% | 4050 |
|
|
2024
Q4 | $160K | Buy |
26,303
+4,749
| +22% | +$28.9K | ﹤0.01% | 3611 |
|
|
2024
Q3 | $356K | Buy |
21,554
+7,027
| +48% | +$116K | ﹤0.01% | 3177 |
|
|
2024
Q2 | $101K | Sell |
14,527
-4,527
| -24% | -$31.5K | ﹤0.01% | 3366 |
|
|
2024
Q1 | $184K | Sell |
19,054
-5,516
| -22% | -$53.3K | ﹤0.01% | 3377 |
|
|
2023
Q4 | $204K | Buy |
24,570
+17,233
| +235% | +$143K | ﹤0.01% | 3498 |
|
|
2023
Q3 | $62K | Sell |
7,337
-232
| -3% | -$1.96K | ﹤0.01% | 3504 |
|
|
2023
Q2 | $70K | Sell |
7,569
-690
| -8% | -$6.38K | ﹤0.01% | 3537 |
|
|
2023
Q1 | $113K | Buy |
8,259
+2,498
| +43% | +$34.2K | ﹤0.01% | 3461 |
|
|
2022
Q4 | $97K | Buy |
5,761
+3,810
| +195% | +$64.2K | ﹤0.01% | 3476 |
|
|
2022
Q3 | $44K | Sell |
1,951
-7,256
| -79% | -$164K | ﹤0.01% | 3693 |
|
|
2022
Q2 | $166K | Sell |
9,207
-161
| -2% | -$2.9K | ﹤0.01% | 3239 |
|
|
2022
Q1 | $251K | Buy |
+9,368
| New | +$251K | ﹤0.01% | 3171 |
|